《国际循环》：在您的临床实践中，哪些患者应用β受体阻滞剂获益最大？
    Myra Klienpeter：对于心梗后患者，我会应用β受体阻滞剂。同样地，对于合并某些类型甲状腺疾病的患者，如果是由于甲状腺疾病导致了高血压，我会应用β受体阻滞剂。   

     <International Circulation>:  In your clinical experience which patients benefit most from the use of beta blockers?  
    Dr Myra Klienpeter:  For the post MI(Myocardial Infarction) patients I will use beta blockers also  these are indicated in those patients who have some thyroid disease and if this is the mechanism for hypertension then I will use beta blockers.